Top Versus Top: Kimberly-Clark Corporation (NYSE:KMB), Meridian Bioscience Inc. (NASDAQ:VIVO)

Kimberly-Clark Corporation (NYSE:KMB)

Kimberly-Clark Corporation (NYSE:KMB) closed at $131.92 on the last trading session with an increase of 2.44%, whereas, it previously closed at $128.78. The company has a market capitalization of $45.8 Billion. The company traded shares of 1.88 Million on the trading day while its three month average volume stands at 1.73 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Kimberly-Clark Corporation (NYSE:KMB) produced diluted EPS of 5.29. The EPS estimate for next year as estimated by analysts is at 7.21 while EPS for next quarter is estimated at 1.8. Earnings per Share growth for this year is reported at -29.4, while the analysts estimated the EPS growth for next year at 7.21% and Earnings growth for next 5 years stands at 4.79% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at -2.7%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Kimberly-Clark Corporation (NYSE:KMB) is at 24.93 while the forward p/e is at 18.3. The P/S or Price to Sales ratio of Kimberly-Clark Corporation (NYSE:KMB) stands at 2.49 and Price to Book or P/B for the most recent quarter stands at 0. The Price to Free Cash Flow ratio or P/FCF is reported at 627.4. The quick ratio and the current ratio of Kimberly-Clark Corporation (NYSE:KMB) are reported at 0.5 and 0.8 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Kimberly-Clark Corporation (NYSE:KMB) stands at 12.1, -797.8 and 25.9 respectively

The trailing twelve month Revenue of Kimberly-Clark Corporation (NYSE:KMB) is reported at 18.38 Billion with income of 1.84 Billion. The outstanding shares of Kimberly-Clark Corporation (NYSE:KMB) are 347.18 Million. The institutional Ownership of the shares of 75.5 stands at 0.80%, this figure is increased 1.14 in the last six months. The insider ownership for the shares of Kimberly-Clark Corporation (NYSE:KMB) is ticked at 0.4%, the figure is plummeted -27% in the last six months.

Some other important financial aspects to be discussed here for Kimberly-Clark Corporation (NYSE:KMB) is the Mean Target Price estimated by the analysts which stands at 139.25. The 52 week high of Kimberly-Clark Corporation (NYSE:KMB) is placed at 143.16 and 52 week low is standing at 100.32.

Performance wise the shares of Kimberly-Clark Corporation (NYSE:KMB) rose up 0.59% for the week, it also fell -6.25% for the monthly performance, while for the quarter it went up -3.06%. The shares increase 9.99% for the half year and flew up for the Year-To-Date performance. The shares of Kimberly-Clark Corporation (NYSE:KMB) grew 13.28% for the yearly performance.

Meridian Bioscience Inc. (NASDAQ:VIVO)

Meridian Bioscience Inc. (NASDAQ:VIVO) closed at $9.95 on the last trading session with an decrease of -0.4%, whereas, it previously closed at $9.99. The company has a market capitalization of $422.78 Million. The company traded shares of 139418 on the trading day while its three month average volume stands at 285.92 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Meridian Bioscience Inc. (NASDAQ:VIVO) produced diluted EPS of 0.59. The EPS estimate for next year as estimated by analysts is at 0.51 while EPS for next quarter is estimated at 0.09. Earnings per Share growth for this year is reported at 1.9, while the analysts estimated the EPS growth for next year at 0.51% and Earnings growth for next 5 years stands at 17% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at -10.7%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Meridian Bioscience Inc. (NASDAQ:VIVO) is at 16.78 while the forward p/e is at 19.51. The P/S or Price to Sales ratio of Meridian Bioscience Inc. (NASDAQ:VIVO) stands at 2.08 and Price to Book or P/B for the most recent quarter stands at 2.25. The Price to Free Cash Flow ratio or P/FCF is reported at 21.79. The quick ratio and the current ratio of Meridian Bioscience Inc. (NASDAQ:VIVO) are reported at 4.7 and 6.9 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Meridian Bioscience Inc. (NASDAQ:VIVO) stands at 9.5, 14.2 and 10.3 respectively

The trailing twelve month Revenue of Meridian Bioscience Inc. (NASDAQ:VIVO) is reported at 203.3 Million with income of 25.4 Million. The outstanding shares of Meridian Bioscience Inc. (NASDAQ:VIVO) are 42.49 Million. The institutional Ownership of the shares of 93.3 stands at 0.80%, this figure is decreased -1.33 in the last six months. The insider ownership for the shares of Meridian Bioscience Inc. (NASDAQ:VIVO) is ticked at 0.3%, the figure is rose 33.52% in the last six months.

Some other important financial aspects to be discussed here for Meridian Bioscience Inc. (NASDAQ:VIVO) is the Mean Target Price estimated by the analysts which stands at 10.67. The 52 week high of Meridian Bioscience Inc. (NASDAQ:VIVO) is placed at 19.84 and 52 week low is standing at 8.96.

Performance wise the shares of Meridian Bioscience Inc. (NASDAQ:VIVO) rose up 1.95% for the week, it also fell -1.58% for the monthly performance, while for the quarter it went up -15.61%. The shares decrease -40.02% for the half year and plummeted for the Year-To-Date performance. The shares of Meridian Bioscience Inc. (NASDAQ:VIVO) shrinked -38.2% for the yearly performance.

You may missed